Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) was up 5.8% during trading on Friday . The company traded as high as $51.69 and last traded at $51.58. Approximately 1,263,697 shares traded hands during trading, a decline of 50% from the average daily volume of 2,536,638 shares. The stock had previously closed at $48.76.
Analysts Set New Price Targets
Several brokerages recently weighed in on ALAB. Roth Mkm reduced their price target on shares of Astera Labs from $85.00 to $60.00 and set a "buy" rating on the stock in a research report on Wednesday, August 7th. Craig Hallum reduced their target price on shares of Astera Labs from $90.00 to $75.00 and set a "buy" rating on the stock in a report on Wednesday, August 7th. Barclays lowered their price target on shares of Astera Labs from $85.00 to $70.00 and set an "overweight" rating for the company in a report on Wednesday, August 7th. Evercore ISI reduced their price objective on Astera Labs from $98.00 to $80.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. Finally, Stifel Nicolaus lowered their price objective on Astera Labs from $87.00 to $80.00 and set a "buy" rating for the company in a research note on Monday, August 5th. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, Astera Labs has an average rating of "Buy" and an average target price of $71.36.
View Our Latest Research Report on ALAB
Astera Labs Stock Up 7.3 %
The firm has a fifty day moving average price of $44.15 and a two-hundred day moving average price of $58.79.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.02. The business had revenue of $76.90 million during the quarter, compared to analysts' expectations of $72.41 million. The company's revenue for the quarter was up 17.8% compared to the same quarter last year. As a group, research analysts anticipate that Astera Labs, Inc. will post -0.54 EPS for the current year.
Insider Buying and Selling at Astera Labs
In other news, insider Sanjay Gajendra sold 76,701 shares of the firm's stock in a transaction that occurred on Tuesday, September 17th. The shares were sold at an average price of $45.32, for a total transaction of $3,476,089.32. Following the transaction, the insider now directly owns 855,000 shares of the company's stock, valued at approximately $38,748,600. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, insider Sanjay Gajendra sold 76,701 shares of the stock in a transaction on Tuesday, September 17th. The stock was sold at an average price of $45.32, for a total transaction of $3,476,089.32. Following the transaction, the insider now owns 855,000 shares of the company's stock, valued at approximately $38,748,600. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Philip Mazzara sold 42,090 shares of Astera Labs stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $40.43, for a total value of $1,701,698.70. Following the completion of the sale, the general counsel now owns 333,474 shares of the company's stock, valued at $13,482,353.82. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 276,791 shares of company stock valued at $12,933,588 in the last three months.
Institutional Investors Weigh In On Astera Labs
Hedge funds have recently modified their holdings of the business. SG Americas Securities LLC purchased a new position in Astera Labs during the third quarter valued at approximately $594,000. Newbridge Financial Services Group Inc. increased its holdings in shares of Astera Labs by 11,920.0% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 3,005 shares of the company's stock valued at $182,000 after acquiring an additional 2,980 shares during the period. Sycomore Asset Management bought a new position in shares of Astera Labs in the 2nd quarter worth $2,038,000. Truist Financial Corp bought a new stake in Astera Labs during the second quarter valued at about $353,000. Finally, The Manufacturers Life Insurance Company purchased a new position in Astera Labs in the second quarter valued at about $341,000.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.